US panel to decide who should get first COVID-19 shots

FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Hans Pennink, File)
FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Hans Pennink, File)

NEW YORK (AP) - An influential government advisory panel convened Tuesday to answer one of the most pressing questions in the U.S. coronavirus outbreak: Who should be at the front of the line when the first vaccine shots become available?

The Advisory Committee on Immunization Practices was scheduled to vote on a proposal that would give priority to health care workers and nursing home patients.

The two groups encompass around 23 million Americans out of a U.S. population of about 330 million.

As the virtual meeting got underway, panel member Dr. Beth Bell, of the University of Washington, noted that on average, one person is dying of COVID-19 per minute in the U.S. right now, "so I guess we are acting none too soon."

Later this month, the Food and Drug Administration will consider authorizing emergency use of two vaccines made by Pfizer and Moderna. Current estimates project no more than 20 million doses of each vaccine will be available by the end of 2020. And each product requires two doses.

As a result, the shots will be rationed in the early stages.

The advisory panel will meet again at some point to decide who should be next in line. Among the possibilities: teachers, police, firefighters, and workers in other essential fields such as food production and transportation; the elderly; and people with underlying medical conditions.

Experts said the vaccine will probably not become widely available in the U.S. until the spring.

The 15-member panel of outside scientific experts, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention, who almost always approves them.

The recommendations are not binding, but for decades, they have been widely heeded by doctors, and they have determined the scope and funding of U.S. vaccination programs.

It will be up to state authorities whether to follow the guidance. It will also be left to them to make further, more detailed decisions if necessary - for example, whether to put emergency room doctors and nurses ahead of other health care workers if vaccine supplies are low.

The outbreak in the U.S. has killed nearly 270,000 people and caused more than 13.5 million confirmed infections, with deaths, hospitalizations and cases rocketing in recent weeks.

About 2 million people are living in nursing homes and other U.S. long-term care facilities. Those patients and the staff members who care for them have accounted for 6 percent of the nation's coronavirus cases and a staggering 39 percent of the deaths, CDC officials said.

The number of health care workers covered by the panel's recommendation would be about 21 million.

That's a broad category that includes medical staff who care for - or come in contact with - patients in hospitals, nursing homes, clinics and doctor's offices. It also includes home health care workers and paramedics. Depending on how state officials apply the panel's recommendations, it could also encompass janitorial staff, food service employees and medical records clerks.

The government estimates people working in health care account for 12 percent of U.S. COVID-19 cases but only about 0.5 percent of deaths. Experts said it's imperative to keep health care workers on their feet so they can administer the shots and tend to the booming number of infected Americans.

For months, members of the immunization panel had said they wouldn't take a vote until the FDA approved a vaccine. That is customary procedure for the panel, with some exceptions, such as during a flu outbreak in 2009. However, late last week, the group scheduled an emergency meeting for Tuesday.

The panel's chairman, Dr. Jose Romero, said the decision stemmed from a realization the states are facing a Friday deadline to place initial orders for the Pfizer vaccine and determine where they should be delivered. The committee decided to meet now to give state and local officials guidance, he said.

However, some panel members and other experts had also grown concerned by comments from Trump administration officials that suggested differing vaccine priorities.

Dr. Deborah Birx, of the White House coronavirus task force, said in a meeting with CDC officials last month that people 65 and older should go to the head of the line, according to a federal official who was not authorized to discuss the matter and spoke to the Associated Press on condition of anonymity.

Then last week U.S. Health and Human Services Secretary Alex Azar stressed ultimately governors will decide who in their states gets the shots. Vice President Mike Pence echoed that view.

Upcoming Events